Martin Visit 1: A 51-year-old man with recent history of weight gain

Title:

Martin Visit 1: A 51-year-old man with recent history of weight gain

Topic: Endocrinology
Relevant Terms: Hypertension, Obesity, Dyslipidemia, Diabetes
Primary Audience: Primary care providers (MDs/ DOs/ NPs/ PAs)
Launch Date: 01-Nov-12
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Managing patients with hyperglycemia and other risk factors

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Demonstrate the ability to identify people who are at increased risk for the development of pre-diabetes, diabetes, and other cardiometabolic risk factors through appropriate screening methods.  
  2. Demonstrate the ability to set individualized glycemic control goals 
  3. Demonstrate the ability to design a glycemic control program using antidiabetes medications and/or insulin in a manner that balances underlying pathophysiology with patient-specific considerations 
  4. Demonstrate the ability to recognize markers of increased risk for development of diabetes-related complications, and initiate office-based complication monitoring and early intervention programs 

    Faculty

    Edward S. Horton, MD
    Professor of Medicine
    Harvard Medical School
    Senior Investigator
    Joslin Diabetes Center
    Boston, MA 
    Jacqueline Shahar, MEd, RCEP, CDE
    Manager, Exercise Services
    Clinical Exercise Physiologist
    Certified Diabetes Educator
    Joslin Diabetes Center
    Boston, MA
    Jeanne Spellman, RD, LDN 
    Research Dietitian
    Joslin Diabetes Center
    Boston, MA
    Planning Committee
     
    Richard S. Beaser, MD*
    Associate Clinical Professor of Medicine
    Harvard Medical School
    Medical Executive Director
    Professional Education
    Joslin Diabetes Center
    Boston, MA
     
    Julie Brown*
    Director
    Professional Education
    Joslin Diabetes Center
    Boston, MA
     
    Karen Kuc*
    Assistant Director
    Professional Education
    Joslin Diabetes Center
    Boston, MA
     
    James Neighbours, Med*
    Associate Director
    Education Design
    Professional Education
    Joslin Diabetes Center
    Boston, MA
     
    Kenneth J. Snow, MD, MBA*
    Assistant Professor of Clinical Medicine
    Harvard Medical School
    Director, Medical Programs, Strategic Initiatives
    Senior Physician, Adult Diabetes Section
    Joslin Diabetes Center
    Boston, MA
     
    *Also on CME Advisory Committee
     
    CME Advisory Committee
     
    Enrique Caballero, MD
    Director, Medical Affairs
    Professional Education
    Director, Latino Diabetes Initiative
    Joslin Diabetes Center
    Boston, MA
     
    Jerry Cavallerano, OD, PhD
    Optometrist
    Beetham Eye Institute
    Joslin Diabetes Center
    Boston, MA
     
    A. Patrick Egan, MD
    Family Practice
    Internal Medicine Specialist
    Dorchester House Multi-Service Center
    Boston, MA
     
    Ann E. Goebel-Fabbri, PhD
    Instructor in Psychiatry
    Harvard Medical School
    Psychologist
    Behavioral and Mental Health Unit
    Joslin Diabetes Center
    Boston, MA
     
    Osama Hamdy, MD, PhD, FACE
    Assistant Professor of Medicine
    Harvard Medical School
    Medical Director, Obesity Clinical Program
    Joslin Diabetes Center
    Boston, MA
     
    Robert C. Stanton, MD
    Associate Professor of Medicine
    Harvard Medical School
    Chief of Nephrology
    Joslin Diabetes Center
    Boston, MA
     
    Howard Wolpert, MD
    Assistant Professor of Medicine
    Harvard Medical School
    Director, Insulin Pump Program
    Senior Physician
    Joslin Diabetes Center
    Boston, MA
     
    DISCLOSURE POLICY STATEMENT
    As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.
     
    Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
     
    If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty has been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of the Joslin Diabetes Center.
     
    Faculty
     
    Dr. Frederick L. Dunn received grant/research support from Merck & Co., Inc., and is a consultant for Lilly USA LLC. Dr. Dunn's spouse receives grant/research support from GlaxoSmithKline, Lilly USA LLC, Novo Nordisk Inc., and Sanofi USA LLC, and is a consultant for Merck & Co., Inc., and Novo Nordisk Inc.
     
    Dr. David Erani is on the speaker's bureau for Amylin Pharmaceuticals, Inc., and Sanofi USA LLC.
     
    Dr. Edward S. Horton is a consultant for Amarin Pharmaceuticals, Inc., Amylin Pharmaceuticals, Inc., Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., and Merck Research Laboratories, Inc.; serves on the data safety monitoring board for GI Dynamics, Inc., Theracos, Inc., and Takeda Pharmaceuticals, Inc.; receives grant/research support from Amylin Pharmaceuticals, Inc., and Eli Lilly and Company; and is on the speakers bureau for Merck & Co., Inc.
     
    Jacqueline I. Shahar has no relevant financial relationships.
     
    Jeanne Spellman has no relevant financial relationships.
     
    Dr. Robert C. Stanton has no relevant financial relationships.
     
    Planning Committee
     
    Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is a consultant for AstraZeneca/Bristol-Myers Squibb Company and CeQur Ltd.
     
    Julie A. Brown, Director, Professional Education, Joslin Diabetes Center, is a consultant for Bristol-Myers Squibb Company.
     
    Karen J. Kuc, MPH, Assistant Director, Grants and Projects, Joslin Diabetes Center, has no relevant financial relationships.
     
    James E. Neighbours, Associate Director, Education Design, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
     
    Dr. Eyiuche Okeke has no relevant financial relationships.
     
    CME Advisory Committee
     
    Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is a consultant for AstraZeneca/Bristol-Myers Squibb Company and CeQur Ltd.
     
    Julie A. Brown, Director, Professional Education, Joslin Diabetes Center, is a consultant for Bristol-Myers Squibb Company.
     
    Dr. Enrique Caballero, Director, Medical Affairs, Professional Education, Director, Latino Diabetes Initiative, Joslin Diabetes Center, is a consultant and on the speakers bureau and scientific advisory board for Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., and Eli Lilly and Company.
     
    Dr. Jerry Cavallerano, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.
     
    Dr. A. Patrick Egan, Family Practice, Internal Medicine Specialist, Dorchester House Multi-Service Center, has no relevant financial relationships.
     
    Anne E. Goebel-Fabbri, Psychologist, Behavioral and Mental Health Unit, Joslin Diabetes Center, has no relevant financial relationships.
     
    Dr. Osama Hamdy, Medical Director, Obesity Clinical Program, Joslin Diabetes Center, is on the speakers bureau for Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Novo Nordisk Inc., sanofi-aventis U.S., and Takeda Pharmaceuticals North America, Inc.
     
    Karen J. Kuc, MPH, Assistant Director, Grants and Projects, Joslin Diabetes Center, has no relevant financial relationships.
     
    James E. Neighbours, Associate Director, Education Design, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
     
    Dr. Robert C. Stanton, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships.
     
    Dr. Howard A. Wolpert, Director of the Insulin Pump Program and Senior Physician, Joslin Diabetes Center, is a consultant for Abbott Diabetes Care; Becton, Dickinson and Company; Insulet Corporation; and Novo Nordisk, Inc.
     
     
    ACCREDITATION STATEMENT
    The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    CREDIT DESIGNATION
    Joslin Diabetes Center designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    To Obtain CME Credits
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the posttest and activity evaluation.
    • Physicians who successfully complete the posttest and evaluation will receive CME credit.
    • You must score 65% or higher on the posttest to receive credit for this activity.
    • All other participants who successfully complete the posttest and evaluation will receive a certificate of participation.
     
    COURSE VIEWING REQUIREMENTS
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac
     
    Release Date: November 1, 2012
    Expiration Date: October 31, 2013
     
     
    ACKNOWLEDGEMENT
    This activity is sponsored by Joslin Diabetes Center.
     
    This activity is supported by educational grants from Daiichi Sankyo, Inc., Novo Nordisk Inc., sanofi-aventis U.S.
     
    If you have any questions regarding this activity, send an email to profedweb@joslin.harvard.edu.
     
    Copyright © 2012 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.